Clinical Trial Update: Triple Antigen vs Monoantigen Immunotherapy for Warts [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial comparing triple antigen intralesional immunotherapy versus monoantigen for treatment of multiple recalcitrant warts has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Warts
• Warts

Drugs mentioned

• Triple Intralesional Immunotherapy

Snippet

Sponsor: Zagazig University | Conditions: Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts | Phase 2, Phase 3 | Status: COMPLETED